Walleye Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Walleye Capital's RARE Position: Q3 2026 in Review
Walleye Capital increased its Ultragenyx Pharmaceutical (RARE) stake by 12% in Q3 2026, buying an estimated $927K and bringing the position to 373,459 shares worth $5.61M. The position accounts for 0.01% of the portfolio, ranked #1785.
Walleye Capital first reported a position in RARE in Q4 2022 and has held it in 16 quarters since. The position peaked at $16.1M in Q2 2024. 264 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- Walleye Capital held 373,459 shares of Ultragenyx Pharmaceutical worth $5.61M as of Q3 2026.
- Walleye Capital bought 38,605 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $927K.
- Ultragenyx Pharmaceutical made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #1785 holding.
- Walleye Capital first reported a position in Ultragenyx Pharmaceutical in Q4 2022 and has held it in 16 quarters since.
- Walleye Capital's Ultragenyx Pharmaceutical position peaked at $16.1M in Q2 2024.
- 264 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.